France / Français
Hypofractionated Radiation in Prostate Cancer Stands Test of Time
For localized prostate cancer, a hypofractionated radiotherapy regimen that cuts treatment time in half continues to have noninferior efficacy long-term relative to a...
17 hours ago - Medscape
Lengthening prostate cancer screening intervals for men could improve outcomes
A new study in JNCI: Journal of the National Cancer Institute, published by Oxford University Press, finds significant benefits to lengthening the amount of time between...
2 days ago - News Medical
How patches made from human placenta could save men's love lives
Patches made from human placenta could prevent men becoming impotent following prostate cancer surgery. Incontinence and erectile dysfunction can occur in up to seven in ten men.
3 days ago - Daily Mail
PET Spots Prostate Cancer Mets Missed on CT, MRI
]]> - SAN FRANCISCO - More than a fourth of men with high-risk prostate cancer had lymph node or distant metastases missed by CT or MRI but detected by PET imaging targeting...
3 days ago - MedPage Today
Stalling Need for ADT in Recurrent Prostate Cancer
]]> - SAN FRANCISCO - Immediate treatment of limited metastatic recurrence of prostate cancer led to a fourfold improvement in the proportion of patients alive without androgen...
4 days ago - MedPage Today
Link Between Genetic Variant and Poor Outcomes in Advanced Prostate Cancer Discovered
A testosterone related genetic variant is associated with faster progression to treatment resistance and shorter overall survival in men with low-volume metastatic prostate...
4 days ago - Medindia Health
HSD3B1 genotype linked to worse outcomes in low-volume metastatic prostate cancer
The adrenal-permissive HSD3B1 genotype appeared associated with earlier castration resistance and shorter OS among men with low-volume metastatic prostate cancer, according to...
6 days ago - Healio
Cholesterol Drugs Might Help Curb Prostate Cancers
The study couldn't prove cause and effect, but it found that statins, taken alone or with metformin, did seem associated with an increase in survival.
6 days ago - Web MD
A Rare QoL Study That Could Change Practice
Two drugs comparably improve survival in the treatment of men with hormone-sensitive prostate cancer, so researchers looked at quality of life to see whether that was a...
6 days ago - Medscape - 2 articles
AI system outperforms pathologists in identifying prostate cancer aggressiveness
The use of artificial intelligence in cancer care holds promise in its ability to improve cancer diagnostics and optimize the oncology workforce. Researchers at Radboud...
7 days ago - Healio - 2 articles
Free Registration
The headlines of Master Doctor
Eat More Fruits and Vegetables to Fend Off Troublesome Menopause Symptoms
Do you want to treat menopause symptoms naturally? Then, start eating a healthy diet rich in fruits and vegetables to keep bothersome menopausal symptoms at bay, suggests a new...
People With Dementia May Double by 2050 Despite Reduction In It's Prevalence
Neww Alzheimer Europe report hosted by Christophe Hansen MEP , says that the number of people with dementia may double by 2050 in spite of decreased prevalence.
Hispanics/Latinos underrepresented in clinical trials for Alzheimer's disease
A University of Houston researcher is working to increase health literacy among Hispanics/Latinos when it comes to Alzheimer's disease.
Everything You Need To Know About Managing Diabetes In Later Life
Diabetes is a disorder that affects your body's metabolism and the way in which it processed for energy. When it comes down to it, all this means is that your body has trouble...
VIDEO: Omidria lowers inflammation, miosis in cataract surgery
ORLANDO - At Cataract Surgery: Telling It Like It Is, I. Paul Singh, MD, discusses specific situations in which Omidria (phenylephrine 1% and ketorolac 0.3% intraocular...
Osteoporosis guideline update recommends romosozumab for women at high...
The Endocrine Society updated its osteoporosis clinical practice guideline to include recommendations for romosozumab, noting that the monthly injection therapy is an...
Clinicians view new Alzheimer's drug with guarded optimism
This year, Biogen is expected to submit a Biologics License Application to the FDA for its anti-amyloid antibody, aducanumab. If approved, it will be the first new drug...
Hypofractionated Radiation in Prostate Cancer Stands Test of Time
For localized prostate cancer, a hypofractionated radiotherapy regimen that cuts treatment time in half continues to have noninferior efficacy long-term relative to a...
Stalked by the Fear That Dementia Is Stalking You
Testing for Alzheimer's disease and other forms of dementia is hardly foolproof, and could even backfire.
Dementia Friendly America Features Webinar on Age-and Dementia Friendly...
Recently, Dementia Friendly America hosted an hour-long webinar that featured the MA Age-Dementia Friendly Integration Tool Kit. Pam McLeod from the Executive Office of Elder...